Altimmune, Inc.
ALTBiotechnology
$2.04−4.67%As of Oct 30vs prior close
- Market cap
- $396.8M
- P/E (TTM)
- –
- From 52W high
- −66.99%
- EPS (LTM)
- -$1.00
- Revenue (LTM)
- $41K
- Net margin
- -214860.98%
Nomior Score
23
Distressed LaggardSpeculativeBottom 9% of the scored universe
Growth—
Quality29
Value38
Momentum30
Resilience29
Growth
−38.45%revenue a year over 9 fiscal years
YE16 $3.2MLTM $41K
Connections
Revenue to profitQ4 YE25
The operating loss was 111127% of revenue, narrower by 386193 pts on a year.
Who owns it
2funds, 1 tracked portfolio